Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4 Registration of securities issued in business combination transactions
- 8.1 EX-8.1 Form of Opinion of Goodwin Procter LLP Relating to Tax Matters
- 8.2 EX-8.2 Form of Opinion of Troutman Sanders LLP
- 12 EX-12 Statement Re Computation of Ratios of Earnings to Fixed Charges
- 23.1 EX-23.1 Consent of Bdo Seidman, LLP
- 23.2 EX-23.2 Consent of KPMG LLP
- 23.3 EX-23.3 Consent of Pricewaterhousecoopers LLP
- 23.4 EX-23.4 Consent of Ernst & Young LLP
- 23.5 EX-23.5 Consent of Colby & Company, PLC
- 99.3 EX-99.3 Consent of Suntrust Robinson Humphrey
- 99.4 EX-99.4 Form of Proxy of Matria
- COVER Cover
Alere similar filings
- 12 Feb 10 Registration of securities issued in business combination transactions
- 3 Apr 08 Registration of securities issued in business combination transactions (amended)
- 26 Mar 08 Registration of securities issued in business combination transactions (amended)
- 14 Feb 08 Registration of securities issued in business combination transactions
- 13 Nov 07 Registration of securities issued in business combination transactions (amended)
- 23 Oct 07 Registration of securities issued in business combination transactions
- 5 Oct 07 Registration of securities issued in business combination transactions (amended)
Filing view
External links
Exhibit 23.4
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated February 23, 2007, with respect to the consolidated financial statements of Biosite Incorporated, included in its Annual Report (Form 10-K) for the year ended December 31, 2006, then incorporated by reference in the Current Report on Form 8-K of Inverness Medical Innovations, Inc., dated June 26, 2007, filed with the Securities and Exchange Commission on July 2, 2007, and as amended on July 20, 2007, and which Form 8-K is incorporated by reference in the proxy statement/prospectus of Inverness Medical Innovations, Inc. that is made a part of this Registration Statement on Form S-4.
/s/ Ernst & Young LLP
San Diego, California
February 14, 2008
February 14, 2008